Immunotherapy
Why Don’t Cancer Immunotherapies Work for Everyone?
Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller
A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.
NHS offers first drug targeting advanced breast cancers driven by BRCA gene mutations
Posted in Medicine, Science on 26th Jan, 2024
by Alex Muller
Talazoparib (Talzenna) will become the NHS’s first targeted treatment for advanced breast cancers caused by mutations to BRCA genes
Immunotherapy's Benefits for Colon Cancer Survivors Continue Long After Treatment Stops
Posted in Medicine on 20th Dec, 2023
by Alex Muller
Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression two years later.
First immunotherapy approved for cervical cancer in England and Scotland
Posted in Medicine on 21st May, 2023
by Alex Muller
The immunotherapy drug pembrolizumab (Keytruda) is now available for people in England and Scotland with some forms of advanced cervical cancer.
Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers
Posted in Medicine, Science on 19th Mar, 2023
by Alex Muller
Some patients still either don't respond to immunotherapy, or if they do, the effects are temporary, which highlights how crucial it is that we better understand the mechanisms leading to cancers resisting this kind of treatment.